Involvement of H- and N-Ras isoforms in transforming growth factor-β1-induced proliferation and in collagen and fibronectin synthesis

Experimental Cell Research

Volumn 312, Issue 11, 2006, Pages 2093-2106

  Martínez Salgado, Carlos ^a   Fuentes Calvo, Isabel ^b   García Cenador, Begoña ^b   Santos, Eugenio ^c   López Novoa, José M ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c CSIC   (Spain)

Author keywords

Collagen; Extracellular matrix; Fibroblasts; Fibronectin; Proliferation; Ras proteins; Transforming growth factor 1

Indexed keywords

ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE FUNCTION; HETEROZYGOTE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE N RAS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 33744937083     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.03.008     Document Type: Article

References (55)

1. Johnson R.J., Alpers C.E., Yoshimura A., Lombardi D., Pritzl P., Floege J., and Schwartz S.M. Renal injury from angiotensin II-mediated hypertension. Hypertension 19 (1992) 464-474
2. Ketteler M., Noble N.A., and Border W.A. Transforming growth factor beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?. Annu. Rev. Physiol. 57 (1995) 279-295
3. Kiyoshi T., Okuda S., Ando T., Iwamoto T., Nakayana M., and Fujishima M. TGF-β in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45 (1994) 525-536
4. Eddy A.A. Molecular insights into renal intersitial fibrosis. J. Am. Soc. Nephrol. 7 (1996) 2495-2508
5. Sharma K., and Ziyadeh F.N. The transforming growth factor-β and the kidney. Semin. Nephrol. 13 (1993) 116-128
6. Haberstroh U., Zahner G., Disser M., Thaiss F., Wolf G., and Stahl R.A.K. TGF-β stimulates rat mesangial cell proliferation in culture. Role of PDGF β-receptor expression. Am. J. Physiol. 264 (1993) F199-F205
7. Border W.A., and Noble W.A. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331 (1994) 1286-1292
8. Edward D.R., Leco K.J., Beaudry P.P., Atadja P.W., Veillette C., and Riabowol K.T. Differential effects of transforming growth factor beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp. Gerontol. 31 (1996) 207-223
9. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev., Cancer 3 (2003) 11-22
10. Colicelli J. Human RAS superfamily proteins and related GTPases. Sci. STKE 2004 (2004) RE13
11. Kretzschmar M., Doody J., Timokhina I., and Massague J. A mechanism of repression of TGFβ/Smad signalling by oncogenic Ras. Genes Dev. 13 (1999) 804-816
12. Park B.J., Park J.I., Byun D.S., Park J.H., and Chi S.G. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signalling pathway in human prostate cancer. Cancer Res. 60 (2000) 3031-3038
13. Iglesias M., Frontelo P., Gamallo C., and Quintanilla M. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene 19 (2000) 4134-4145
14. Alcock R.A., Dey S., Chendil D., Inayat M.S., Mohiuddin M., Hartman G., Chatfield L.K., Gallichio V.S., and Ahmed M.M. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene 21 (2002) 7883-7890
15. Barbacid M. Ras genes. Annu. Rev. Biochem. 56 (1987) 779-827
16. Dhanasekavan N., and Premkumar E. Signalling by dual specificity kinases. Oncogene 17 (1998) 1447-1455
17. Kerkhoff E., and Rapp U.R. Cell cycle targets or Ras/Raf signalling. Oncogene 17 (1988) 1457-1462
18. Umanoff H., Edelmann W., Pellicer A., and Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1709-1713
19. Esteban L.M., Vicario-Abejón C., Fernández-Medarde A., Swaminathan N., Yienger K., López E., Malumbres M., McKay R., Ward J.M., Pellicer A., and Santos E. Targeted genomic disruption of H-Ras and N-Ras, individually or in combination, reveals dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21 (2001) 1444-1452
20. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R.T., Umanoff H., Edelmann W., Kucherlapati R., and Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Gene Dev. 11 (1997) 2468-2481
21. Koera K., Nakamura K., Nakao K., Miyoshi J., Toyoshima K., Hatta T., Otani H., Aiba A., and Katsuki M. K-ras is essential for the development of the mouse embryo. Oncogene 15 (1997) 1151-1159
22. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
23. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., and Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6062-6067
24. Rodriguez-Barbero A., Obreo J., Yuste L., Montero J.C., Rodriguez-Pena A., Pandiella A., Bernabeu C., and Lopez-Novoa J.M. Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett. 513 (2002) 282-288
25. A. Rodriguez-Peña, N. Docherthy, C. Guerrero, M. Grande, E. Santos, N. Eleno, J.M. López-Novoa, Contribution of Ras GTPAse/MAP kinase to renal fibrosis induced by unilateral ureteral obstruction, Hypertension 42 (2003) 441, P192.
26. Gillies R.J., Didier N., and Denton M. Determination of cell number in monolayer cultures. Anal. Biochem. 159 (1986) 109-113
27. Cortes P., Riser B.L., Asano K., Rodríguez-Barbero A., Narins R.G., and Yee J. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int. 54 (1998) 1985-1998
28. Varga J., and Bashey R.I. Regulation of connective tissue synthesis in systemic sclerosis. Int. Rev. Immunol. 12 (1995) 187-199
29. Branton M.H., and Kopp J.B. TGF-β and fibrosis. Microbes Infect. 1 (1999) 1349-1365
30. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor β in human diseases. N. Engl. J. Med. 342 (2000) 1350-1358
31. Cheng J., and Grande J.P. Transforming growth factor β signal transduction and progressive renal disease. Exp. Biol. Med. 227 (2002) 943-956
32. Wisdom R., Huynh L., Hsia D., and Kim S. RAS and TGF-β exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 24 (2005) 7043-7054
33. Ricupero D.A., Poliks C.F., Rishikof D.C., Cuttle K.A., Kuang P.P., and Goldstein R.H. Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am. J. Physiol. 281 (2001) C99-C105
34. Ivarsson M., McWhirter A., Borg T.K., and Rubin K. Type I collagen synthesis in cultured human fibroblasts: regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers. Matrix Biol. 16 (1998) 409-425
35. Zhang D., Bar-Eli M., Meloche S., and Brodt P. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/Erk pathways transmit opposing signals. J. Biol. Chem. 19 (2004) 19483-19490
36. Neugarten J., Medve I., Lei J., and Silbiger S. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am. J. Physiol. 277 (1999) F875-F881
37. Mucsi I., Skorecki K.L., and Goldberg H.J. Extracellular signal regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor β on gene expression. J. Biol. Chem. 271 (1996) 16567-16572
38. Davis B., Chen A., and Beno D. Raf and mitogen-activated protein kinase regulate stellate cell collagen gene expression. J. Biol. Chem. 271 (1996) 11039-11042
39. Sveglati-Baroni G., Ridolfi F., di Sario A., Casini A., Marucci L., Gaggiotti G., Orlandoni P., Macarri G., Perego L., Benedetti A., and Folli F. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29 (1999) 1743-1751
40. Hayashida T., Poncelet A.C., Hubchak S., and Schnaper H.W. TGF-β 1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 56 (1999) 1710-1720
41. Tharaux P.L., Chatziantoniou C., Fakhouri F., and Dussaule J.C. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36 (2000) 330-336
42. Reunanen N., Foschi M., Han J., and Cari V.K. Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J. Biol. Chem. 275 (2000) 34634-34639
43. Ishida T., Haneda M., Maeda S., Koya D., and Kikkawa R. Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes 48 (1999) 595-602
44. Pat B.K., Cuttle L., Watters D., Yang T., Johnson D.W., and Gobe G.C. Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations. Nephrology (Carlton) 8 (2003) 196-204
45. Inoki K., Haneda M., Ishida T., Mori H., Maeda S., Koya D., Sugimoto T., and Kikkawa R. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Inter., Suppl. 77 (2000) S76-S80
46. Munshi H.G., Wu Y.I., Mukhopadhyay S., Ottaviano A.J., Sassano A., Koblinski J.E., Platanias L.C., and Stack M.S. Differential regulation of membrane type 1-matrix metalloproteinase activity by Erk1/2 and p38 MAPK-modulated tissue inhibitor of metalloproteinase 2 expression controls transforming Growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279 (2004) 39042-39050
47. Cunliffe I.A., Rees R.C., and Rennie I.G. The effect of TGF-beta 1 and TGF-beta 2 on the proliferation of human Tenon's capsule fibroblasts in tissue culture. Acta Ophthalmol. Scand. 74 (1996) 31-35
48. Kay E.P., Lee M.S., Seong G.J., and Lee Y.G. TGF-beta stimulates cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts. Curr. Eye Res. 17 (1998) 286-293
49. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (2003) 835-870
50. Marshall C.J. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
51. Kahan C., Seuwen K., Meloche S., and Pouyssegur J. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J. Biol. Chem. 267 (1992) 13369-13375
52. Pumiglia K.M., and Decker S.J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 448-452
53. Qui M.S., and Green S.H. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged Erk activity. Neuron 9 (1992) 705-717
54. Roovers K., and Assoian R.K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays 22 (2000) 818-826
55. Phan T.T., Lim I.J., Bay B.H., Qi R., Longaker M.T., Lee S.T., and Huynh H.T. Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am. J. Physiol. 284 (2003) C860-C869